“I am devoting my research to the study of cancer prevention and treatment in individuals at high risk of developing the disease.”
Dr. Kelly Metcalfe’s research focuses on the prevention and treatment of hereditary breast cancer. She has published extensively on the psychosocial implications of preventive options, including prophylactic mastectomy and oophorectomy. Dr. Metcalfe has developed a decision aid for individuals with a BRCA1 or BRCA2 mutation to help them assess their breast cancer prevention choices.

The recipient of a New Investigator Award from the Canadian Institutes of Health Research, Dr. Metcalfe has received many awards recognizing her contributions to breast cancer research, most recently the Wendy Lack Women of Action Scientific Award from the Israel Cancer Research Foundation. She is a Fellow of the Canadian Academy of Health Sciences and a Fellow of the American Academy of Nursing. In 2022, she was awarded the Canadian Nurses Association Order of Merit for Research.

Dr. Metcalfe is a Senior Scientist with Women’s College Research Institute where she collaborates with the team of investigators in the Familial Breast Cancer Research Unit. At the Unit Clinic, she provides counselling to women identified with a BRCA mutation to help facilitate their decision-making about the options that are available to prevent breast cancer.

Media availability: TV, Radio, Print/Online